5500 Wayzata Blvd.
Suite 1600
Golden Valley, MN 55416
United States
844 672 4357
https://www.inspiresleep.com
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 1.011
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Richard J. Buchholz | Chief Financial Officer | 663,43k | 1,37M | 1968 |
Mr. Philip J. Ebeling | Chief Operating Officer | 675,41k | 561,26k | 1971 |
Mr. Randall A. Ban | Chief Commercial Officer | 624,45k | 5,11M | 1965 |
Dr. Charisse Y. Sparks FAAOS, M.D. | Chief Medical Officer | 31,35k | N/D | 1963 |
Mr. Carlton W. Weatherby | Chief Strategy Officer | 553,29k | N/D | 1985 |
Mr. John C. Rondoni | Chief Technology Officer | 576,72k | 2,48M | 1980 |
Ms. Ezgi Yagci | Vice President of Investor Relations | N/D | N/D | N/D |
Mr. Bryan K. Phillips | Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary | 639,9k | N/D | 1971 |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
L'ISS Governance QualityScore di Inspire Medical Systems, Inc. al 1 maggio 2024 è 5. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 4; diritti degli azionisti: 8; retribuzione: 5.